• Subscribe
  • Newsfeed
  • About
Announce News

Hostplus

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosisBrainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
    Brainomix
    24 Feb 2026

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis

    Brainomix develops medical imaging software that helps clinicians assess stroke and lung fibrosis using automated image analysis. Its platforms support diagnosis and treatment decisions by analysing scans and providing clinical insights at the point of care.

    Brainomix completes £14m Series C led by Parkwalk Advisors to advance AI imaging technology in healthcareBrainomix completes £14m Series C led by Parkwalk Advisors to advance AI imaging technology in healthcare
    Brainomix
    20 Mar 2025

    Brainomix completes £14m Series C led by Parkwalk Advisors to advance AI imaging technology in healthcare

    Brainomix develops AI-powered medical imaging software for stroke and lung disease, helping clinicians diagnose conditions faster and make better treatment decisions using automated biomarkers.

Hostplus
    • Health
  • 2(12 months)
  • hostplus.com.au
  • Update Information

More venture news

  • Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
    Brainomix
    24 Feb 2026

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis

    ExtensionHealth
  • Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy
    Centauri Therapeutics
    24 Feb 2026

    Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy

    ExtensionLife Sciences
  • SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI
    SurrealDB
    17 Feb 2026

    SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI

    ExtensionEnterprise

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn